Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
9.65
+0.28 (2.99%)
At close: Sep 18, 2026, 4:00 PM EDT
9.65
0.00 (0.00%)
Pre-market: Sep 21, 2026, 4:02 AM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $350.22 million as of September 18, 2026.
Market Cap
350.22M
Enterprise Value
158.05M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.65
ChartMarket Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has decreased from $481.24M to $350.22M, a decrease of -27.23%. That is a compound annual growth rate of -30.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 350.22M | -35.11% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 369.94M |
| DiaMedica Therapeutics | 369.39M |
| Orchestra BioMed Holdings | 365.44M |
| Ocugen | 359.46M |
| Enanta Pharmaceuticals | 355.33M |
| X4 Pharmaceuticals | 354.95M |
| Agenus | 353.41M |
| Lexeo Therapeutics | 344.58M |